RUVOLO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 37.922
AS - Asia 6.138
EU - Europa 4.337
Continente sconosciuto - Info sul continente non disponibili 1.058
SA - Sud America 847
AF - Africa 121
OC - Oceania 44
Totale 50.467
Nazione #
US - Stati Uniti d'America 37.732
SG - Singapore 2.992
CN - Cina 1.091
IT - Italia 866
RU - Federazione Russa 754
BR - Brasile 676
IE - Irlanda 590
HK - Hong Kong 537
VN - Vietnam 436
FR - Francia 408
DE - Germania 370
SE - Svezia 315
UA - Ucraina 293
BD - Bangladesh 260
GB - Regno Unito 260
JP - Giappone 180
KR - Corea 153
FI - Finlandia 133
CA - Canada 113
IN - India 110
ID - Indonesia 83
NL - Olanda 74
AR - Argentina 68
PL - Polonia 67
BE - Belgio 63
MX - Messico 41
ZA - Sudafrica 40
TR - Turchia 38
ES - Italia 32
IQ - Iraq 31
AT - Austria 29
EC - Ecuador 25
AU - Australia 24
EG - Egitto 23
PH - Filippine 23
CO - Colombia 22
PK - Pakistan 22
KG - Kirghizistan 21
MY - Malesia 21
UZ - Uzbekistan 21
CZ - Repubblica Ceca 20
CL - Cile 19
NZ - Nuova Zelanda 19
MA - Marocco 18
NP - Nepal 16
AE - Emirati Arabi Uniti 15
LT - Lituania 14
TN - Tunisia 13
VE - Venezuela 13
IR - Iran 12
PE - Perù 11
TH - Thailandia 11
SA - Arabia Saudita 10
DZ - Algeria 9
PY - Paraguay 9
CR - Costa Rica 7
EU - Europa 7
JM - Giamaica 7
JO - Giordania 7
TW - Taiwan 7
AZ - Azerbaigian 6
RO - Romania 6
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
KW - Kuwait 5
MD - Moldavia 5
NO - Norvegia 5
PT - Portogallo 5
CY - Cipro 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HU - Ungheria 4
LK - Sri Lanka 4
PS - Palestinian Territory 4
BH - Bahrain 3
CH - Svizzera 3
CI - Costa d'Avorio 3
ET - Etiopia 3
KZ - Kazakistan 3
LB - Libano 3
PA - Panama 3
PR - Porto Rico 3
SI - Slovenia 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
CU - Cuba 2
GT - Guatemala 2
IL - Israele 2
LC - Santa Lucia 2
LV - Lettonia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
Totale 49.408
Città #
Wilmington 9.748
Houston 9.277
Woodbridge 6.792
Singapore 1.537
Fairfield 1.189
Ashburn 997
Chandler 831
Ann Arbor 811
San Jose 746
Council Bluffs 531
Hong Kong 529
Seattle 510
Dublin 470
Beijing 460
Dallas 427
Cambridge 402
Medford 342
Rome 293
New York 290
Santa Clara 289
Dearborn 263
Los Angeles 219
The Dalles 216
Tokyo 166
Lawrence 162
Jacksonville 159
Lauterbourg 149
Ho Chi Minh City 145
Moscow 124
Buffalo 102
Hanoi 92
Menlo Park 86
Milan 83
São Paulo 74
London 67
Jakarta 66
San Diego 64
Brussels 62
Columbus 59
Zhengzhou 55
Redondo Beach 53
Helsinki 51
North Bergen 49
Orem 48
Nuremberg 47
Phoenix 40
Redwood City 39
Montreal 35
Atlanta 34
Warsaw 34
Chennai 33
Chicago 32
Seoul 32
Boardman 30
Brooklyn 30
San Francisco 29
Amsterdam 28
Denver 27
Norwalk 27
Shanghai 27
Stockholm 27
Kraków 26
Lappeenranta 26
Johannesburg 25
Nanjing 22
Palermo 22
Poplar 22
Rio de Janeiro 22
Verona 22
Munich 21
Frankfurt am Main 20
Hangzhou 20
Palo Alto 20
Toronto 20
Da Nang 19
Hefei 19
Mountain View 19
Miami 17
Belo Horizonte 16
Boston 16
Del Norte 16
Guangzhou 16
Haiphong 16
Kilburn 16
Manchester 16
Philadelphia 16
Mumbai 15
Salt Lake City 15
Washington 15
Baghdad 14
Biên Hòa 14
Bologna 14
Brno 14
Cairo 14
Charlotte 14
Naples 14
Ankara 13
Kuala Lumpur 13
Kunming 13
Tashkent 13
Totale 40.321
Nome #
1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study 845
Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ™ mitral valve bioprosthesis: first procedure description and 30-day follow-up 544
Vascular ageing and endothelial cell senescence: Molecular mechanisms of physiology and diseases 513
Toll-like receptor-4 signaling pathway in aorta aging and diseases: "its double nature" 489
Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: A 4.8-year prospective cohort study 487
Acute Type A Aortic Dissection: Beyond the Diameter 484
Warm blood cardioplegia versus cold crystalloid cardioplegia for myocardial protection during coronary artery bypass grafting surgery 463
Type A aortic dissection and postoperative malperfusion: Analysis of in-hospital and long-term results in a reference center for aortic emergency surgery 462
Cardiac surgery with extracorporeal circulation and concomitant malignancy: early and long-term results 460
The Role of the Patient-Prosthesis Mismatch after Aortic Valve Replacement: The Prognostic Signicance 457
Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals? 455
185 * RED BLOOD CELL DISTRIBUTION WIDTH PREDICTS MORBIDITY AND MORTALITY AFTER AORTIC VALVE REPLACEMENT 448
Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results 447
Can the TLR-4-mediated signaling pathway be "a key inflammatory promoter for sporadic TAA"? 446
Total arch versus hemiarch replacement for type a acute aortic dissection: A single-center experience 443
Focus on the unique mechanisms involved in thoracic aortic aneurysm formation in bicuspid aortic valve versus tricuspid aortic valve patients: Clinical implications of a pilot study 442
Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and Perspectives. 441
Transcatheter aortic valve replacement for a bicuspid aortic valve following replacement of the ascending aorta 434
Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patients 429
Identification of three particular morphological phenotypes in sporadic thoracic aortic aneurysm: Phenotype III as sporadic thoracic aortic aneurysm biomarker in aged individuals 429
A particular phenotype of ascending aorta aneurysms as precursor of type A aortic dissection. 428
Ascending aortic aneurysms: Indications to open repair 427
Penn classification in acute aortic dissection patients 424
Single versus double antiplatelet therapy in patients undergoing coronary artery bypass grafting with coronary endarterectomy: Mid-term results and clinical implications 423
A particular phenotype of ascending aorta aneurysm as precursor of type A Dissection 422
Transcatheter aortic valve implantation compared with surgical aortic valve replacement in low-risk patients 420
Twenty-year results of aortic root surgery in patients affected by Marfan Syndrome: A single-center follow-up experience 419
Trans-catheter mitral valve implantation for mitral regurgitation: clinical case description and literature review. 418
Focusing on Patient Subcategories: When Could We Expect a Suboptimal Late Result after Coronary Endarterectomy? 414
The Treatment of Aortic Valve Stenosis in Patients at Intermediate-High Risk 411
The role of inflammation in type A aortic dissection: A pilot study 410
Outcomes of aortic valve repair according to valve morphology and surgical techniques 409
Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry 407
Normally functioning cooley-cutter mechanical prosthesis associated with ascending aorta aneurysm 39 years after implantation 404
Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation 402
Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis: Results from an intermediate risk propensity-matched population of the Italian OBSERVANT study 396
Coronary artery bypass grafting with adjunctive endarterectomy: A mandatory procedure in complex revascularizations. current results and postoperative considerations 395
Role of TGF- β pathway polymorphisms in sporadic thoracic aortic aneurysm: Rs900 TGF- β 2 is a marker of differential gender susceptibility 394
In-hospital and mid-term outcomes of patients operated on for type A acute aortic dissection complicated by postoperative malperfusion 390
Long-Term Results After Repair of Type A Acute Aortic Dissection According to False Lumen Patency 390
A simple risk tool (the OBSERVANT score) for prediction of 30-day mortality after transcatheter aortic valve replacement 386
Matrix Metalloproteinases (MMPs), Their Genetic Variants and miRNA in Mitral Valve Diseases: Potential Biomarker Tools and Targets for Personalized Treatments. 385
Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5 384
Red Blood Cells Distribution Width as Biomarker of Worsening in Atherosclerosis 378
Valve prosthesis-patient mismatch: hemodynamic, echocardiographic and clinical consequences. 375
Transcatheter mitral valve replacement with a novel self-expandable prosthesis: Single institutional experience Procedural outcomes and follow-up 375
Valves in the Heart of the Big Apple VIII: Evaluation and Management of Valvular Heart Diseases 2014. Fifth Annual Joint Scientific Session of the Heart Valve Society of America and Society of Heart Valve Diseases, New York City, N.Y., May 8-10, 2014: Abstracts 372
The effect of postoperative malperfusion after surgical treatment of type A acute aortic dissection on early and mid-term survival. 370
Early neurologic injury after emergency aortic arch surgery: A single center experience of different cerebral hypothermic antegrade perfusion techniques 369
Cardiovascular disease in aging: an overview on thoracic aortic aneurysm as an emerging inflammatory disease 367
Surgical treatment of the ascending aorta aneurysm associated to bicuspid aortic valve 364
Outcome after general anesthesia versus monitored anesthesia care in transfemoral Transcatheter aortic valve replacement 363
Results of the OBSERVANT study: Clinical features and short-term outcomes of the enlisted population who underwent aortic valve replacement (transcatheter versus surgical)|Risultati dello studio OBSERVANT: Caratteristiche cliniche ed esiti a breve termine della popolazione arruolata sottoposta a sostituzione valvolare aortica (transcatetere versus chirurgica) 362
Long-term results of aortic root surgery in Marfan syndrome patients: A single-center experience 362
Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement. 360
Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement 356
Effects of psychiatric disorders on Type A acute aortic dissection pathogenesis and analysis of follow-up results 355
Histological and genetic studies in patients with bicuspid aortic valve and ascending aorta complications. 353
Is the Penn classification a valid method to predict in-hospital mortality and outcomes after surgery in acute type A aortic dissection patients? 351
Polymorphisms of endothelial nitric oxide gene as strong risk factors of sporadic ascending aorta aneurysm 349
Histological and genetic study in patients with bicuspid aortic valve and ascending aorta complications 349
CRT-723 Is the Sporadic Thoracic Aortic Aneurysm the Result of an Inflammatory Process? 348
PAS-Port in coronary artery bypass grafting 347
Eicosanoids and aneurysms 345
Could the prophylactic replacement of the aortic root reduce the risk of dissection in patient with ascending aorta aneurysm? 339
Clinical outcome and hemodynamic performance of st. Jude trifecta aortic prosthesis: Short-term follow-up and risk factors analysis 333
A 3D geometric morphometric analysis of the palatal morphology in marfan’s syndrome: A preliminary study. 333
Role of Polymorphisms of Angiotensin Converting Enzyme Gene in Thoracic Ascending Aneurysm 332
Mitral valve annuloplasty and papillary muscle relocation oriented by 3-dimensional transesophageal echocardiography for severe functional mitral regurgitation. 326
Characterisation of the Mechanisms Involved in Thoracic Aortic Aneurysm Formation in Bicuspid Aortic Valve Patients versus Tricuspid Aortic Valve: Clinical Implications of a Pilot Study 326
Improvement in myocardial function and haemodynamic performance with administration of C1 inhibitor in patients with STEMI undergone revascularization 325
Pathophysiological implications of Inflammation and Genetic Inflammatory Factors in hypertensive and old patients affected by thoracic Aortic Aneurysm 322
Coronary artery bypass graft surgery in a patient with a giant pericardial cyst 321
OC17 CORONARY ENDARTERECTOMY: AN OLD TOOL FOR PATIENTS CURRENTLY OPERATED ON CABG. LONG-TERM RESULTS, RISK FACTORS ANALYSIS. 318
How to deal with aortic valve stenosis in patients at intermediate-high risk in the modern era 317
A Typical Immune T/B Subset Profile Characterizes Bicuspid Aortic Valve: In an Old Status? 316
Sporadic Ascending Aortic Aneurysm: Is it the Diameter of Ascending Aorta a Good Criterion for Surgical Indication? 313
Can the aortic wall communicate with us? 306
Role of the inducibile nitric oxide synthase in inflammatory pathogenesis of the ascending aortic aneurysm 291
Polimorfismi morfofunzionali degli aneurismi degenerative non aterosclerotici della aorta ascendente: Studio anatomo-clinico su espianti chirurgici 289
Sporadic Ascending Aneurysm: It is the diameter of ascending aorta a good criteria for surgical indication? 288
Multifocal cardiac hemangioma 288
Marfan syndrome in children: correlation between musculoskeletal features and cardiac Z-score. 288
Gelatinolytic activity in gingival crevicular fluid and saliva of growing patients with Marfan syndrome: a case-control study 275
Role of bone marrow mesenchymal stem cell in the stabilization of elastace-induced ascending aortic aneurysm in a rat model 273
Acute Myocardial Infarction Ten Days after Bentall Procedure due to Coronary Embolism: Etiology Discussion and Rare Case Presentation. 271
Red Blood Cell Distribution Width, Vascular Aging Biomarkers, and Endothelial Progenitor Cells for Predicting Vascular Aging and Diagnosing/Prognosing Age-Related Degenerative Arterial Diseases 270
Genotypic categorization of loeys-dietz syndrome based on 24 novel families and literature data 264
Obstructive sleep apnea in children with Marfan syndrome: Relationships between three-dimensional palatal morphology and apnea-hypopnea index. 262
Regulation of PDE5 expression in human aorta and thoracic aortic aneurysms 259
Paravalvular leak of a mechanical mitral valve prosthesis associated with Burkholderia cepacia subacute endocarditis: A rare case successfully treated by multidisciplinary approach 256
3D evaluation of maxillary morphology in Marfan growing subjects: a controlled clinical study 256
Percutaneous aortic leak closure in a small and frail annulus after double heart valve replacement 255
Coronary endarterectomy: an old tool for patients currently operated on coronary artery bypass grafting. Long-term results, risk factors analysis. 253
Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding 250
Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: A 10-year single center experience 250
Biomarkers for vascular ageing in aorta tissues and blood samples 246
Early and mid-term results in patients undergoing primary CABG in comparison with patients with PCI prior to CABG 241
Deregulation of Notch1 pathway and circulating endothelial progenitor cell (EPC) number in patients with bicuspid aortic valve with and without ascending aorta aneurysm 241
Coronary embolism following Bentall procedure and hemiarch resection for acute Type A aortic dissection 241
Totale 36.880
Categoria #
all - tutte 139.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.692 0 149 96 67 112 188 71 130 137 197 110 435
2022/20232.126 213 171 77 251 181 505 186 173 203 7 85 74
2023/20241.166 97 30 59 13 106 247 58 235 40 90 26 165
2024/20254.765 350 1.029 463 291 75 336 238 212 462 456 425 428
2025/20267.989 607 454 1.158 594 657 263 1.032 953 847 654 437 333
2026/2027789 411 378 0 0 0 0 0 0 0 0 0 0
Totale 50.467